Aspirin for prevention of cardiovascular events

BMJ

Volumn 337, Issue 7677, 2008, Pages 1005-1006

  Hiatt, William R ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIOXIDANT; PLACEBO; CARDIOVASCULAR AGENT;

ACUTE HEART INFARCTION; ARTERY DISEASE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DRUG EFFICACY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL HEMORRHAGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROPHYLAXIS; STABLE ANGINA PECTORIS; STROKE; TREATMENT OUTCOME; TREATMENT RESPONSE; NOTE;

ASPIRIN; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; HUMANS;

EID: 54949138083     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.a1806     Document Type: Editorial

References (8)

1. Belch J, Macuish A, Campbell I, Cobbe S, Taylor R, Prescott R, et al. The prevention of progression of arterial disease and diabetes (POPAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008;337:a1806.
2. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
3. Lechat P, Priollet P. Prevention of major ischemic events in lower limb arterial disease: does aspirin play a role? J Mal Vasc 2006;31:129-34.
4. Fleming T, Nissen SE, Borer JS, Armstrong PW. Report from the 100th cardiovascular and renal drugs advisory committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD. Circulation 2004;109:e9004-5.
5. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
6. Final report on the aspirin component of the ongoing physicians' health study. Steering committee of the Physicians' Health Study Research Group. N Engl J Med 1989;321:129-35.
7. Nicolucci A, De BG, Sacco M, Tognoni G. AHA/ADA vs ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions. Eur Heart J 2007;28:1925-7.
8. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197-208.